A Curated Platform of Equity & Options Market Intelligence
Select Page

ALDX

Search by
TICKER SYMBOL

Aldeyra Therapeutics Inc

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing

3.27

0.19

(6.169%)

Volume:

859,171

52 week range:

1.42 - 11.97

Market Cap:

192.589M

Company Description:

dedicated to improving lives by developing products that treat aldehyde-mediated diseases. we are a biotechnology company focused primarily on the development of new products for inflammation, inborn errors of metabolism, and other diseases that are thought to be related to endogenously generated toxic and pro-inflammatory chemical species known as aldehydes. we are developing adx-102 (formerly ns2), as well as other novel product candidates that are designed specifically to sequester aldehydes, for the treatment of: • noninfectious anterior uveitis, a rare severe inflammatory eye disease that can lead to blindness; • allergic conjunctivitis, a common disease that affects more than 20% of the population worldwide, and related rare allergic ocular diseases that are characterized by inflammation of the conjunctiva (a membrane covering part of the front of the eye), resulting in ocular itching, excessive tear production, swelling, and redness; • dry eye disease, a common inflammatory dise